GlaxoSmithKline has hired computational drug design specialist Dr Kim Branson to expand its artificial intelligence and machine learning unit. Branson joins the pharma group as senior vice ...
GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback